Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general

Takuya Hasegawa1, Masanori Asakura1, Kazuo Eguchi2

  • 1Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Insights

Plasma B-type natriuretic peptide (BNP) levels indicate higher coronary heart disease (CHD) risk in community populations. Elevated BNP effectively identifies individuals with moderate to high CHD risk, even without existing heart or kidney issues.

Area of Science:

  • Cardiology
  • Biomarkers
  • Preventive Medicine

Background:

  • B-type natriuretic peptide (BNP) is linked to cardiovascular prognosis.
  • Accumulated cardiovascular risk factors predict future disease.
  • BNP's role as a comprehensive marker for risk factor accumulation is under-explored.

Purpose of the Study:

  • To investigate if plasma BNP levels serve as a comprehensive marker for accumulated cardiovascular risk factors.
  • To assess the association between BNP levels and coronary heart disease (CHD) risk in a community-dwelling population.

Main Methods:

  • A study of 1530 community-dwelling Japanese subjects (mean age 62) without heart disease or renal dysfunction.
  • Coronary heart disease (CHD) risk was estimated using the Framingham function, categorizing participants into low, moderate, and high-risk groups.
  • Plasma BNP levels were measured and analyzed for their ability to detect moderate- and high-risk subjects.

Main Results:

  • The prevalence of moderate- and high-risk CHD subjects increased with higher plasma BNP levels in both genders.
  • Plasma BNP demonstrated modest ability to detect these risk groups (AUC 0.755 for men, 0.700 for women).
  • Optimal BNP thresholds for identifying moderate- and high-risk individuals were 12.0 pg/mL and 22.0 pg/mL, respectively, with good sensitivity and specificity.

Conclusions:

  • Elevated plasma BNP levels are associated with increased CHD risk in a population free from overt heart disease or renal dysfunction.
  • BNP can serve as a valuable biomarker for identifying individuals with accumulated cardiovascular risk factors.
  • These findings support the use of BNP testing in community health checkups for cardiovascular risk assessment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
956
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
2.0K